We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 59

Price manipulation in China may trigger criminal liability: an update
  • McDermott Will & Emery
  • China
  • April 16 2010

While the just-announced results of an investigation into a rice powder price-manipulation scheme have shed light on the application of recent pricing and anti-monopoly laws in the People's Republic of China, it remains to be seen how authorities will reconcile outstanding differences in the laws


Chinese government issues Finalized Guidelines on Relevant Market Definition
  • McDermott Will & Emery
  • China
  • August 31 2009

On May 24, 2009, the Anti-Monopoly Committee of the State Council issued the finalized Guidelines on Relevant Market Definition (Guidelines


China issues draft Regulations on Anti-Price-Monopoly for comments
  • McDermott Will & Emery
  • China
  • August 31 2009

On August 12, 2009, China’s National Development and Reform Commission (NDRC) published a draft version of the Regulations on Anti-Price-Monopoly to solicit opinions from the public


Chinese antitrust agency blocks Coca-Cola transaction
  • McDermott Will & Emery
  • China
  • May 1 2009

China's Ministry of Commerce (MOFCOM) on March 18, 2009, announced that it was prohibiting Coca-Cola's $2.4 billion bid to acquire Huiyuan Juice, China's leading fruit juice maker


New Chinese health and pharmaceuticals regulations
  • McDermott Will & Emery
  • China
  • June 28 2010

Regulation by the Chinese Government of the health and pharmaceuticals industry generally follows a cyclical pattern: a major incident occurs that impacts the Chinese public and triggers government investigations, resulting in changes to the regulation or regulatory system to close the loopholes found in the old legal regime that allowed the incident to happen in the first place


China to scrutinize M&A by national security
  • McDermott Will & Emery
  • China
  • February 14 2011

On 12 February 2011, the Office of the State Council issued a circular to launch a state-level investment review body to check that merger and acquisition deals struck by non-Chinese firms in China do not endanger "national security."


China Auto Dealers Association files anti-monopoly complaint against Beijing Benz
  • McDermott Will & Emery
  • China
  • April 28 2011

The China Automobile Dealers Association recently issued a formal complaint to Mercedes-Benz Beijing regarding its allegedly illegal "double limit" policy for car dealersminimum prices and restrictions on sales into other dealers territoriesrevealing tension between a widespread industry practice and China's Anti-Monopoly Law


China to control pricing costs of state-owned enterprises
  • McDermott Will & Emery
  • China
  • August 12 2010

The Legislative Affairs Office of the State Council recently issued an act to supervise and regulate government-set and government-guided prices through pricing-cost examinations, in order to prevent them from becoming inflated above national averages


National security review: is it a game of tit for tat?
  • McDermott Will & Emery
  • China
  • April 4 2011

On 12 February 2011, the Office of the State Council of China issued a circular announcing the formation of a state-level investment body to review China-based mergers and acquisitions (M&A) deals which involve non-Chinese firms and which might endanger China's "national security"


“Public policy” and the enforcement of foreign arbitration awards in China
  • McDermott Will & Emery
  • China
  • November 22 2010

In 1986, the People's Republic of China ratified the Convention on the Recognition and Enforcement of Foreign Arbitral Awards (the New York Convention), the multinational treaty that requires the courts of signatory states to enforce foreign arbitral awards